Author

Cesar Sanchez

Instituto Nacional de Salud

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Genetics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:statistical model· 2 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:chromatin & epigenetic regulation· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1

Frequent Co-Authors

Carlos PadillaiD· 1 shared Diego M. Véliz-OtaniiD· 1 shared Eimear E. KennyiD· 1 shared Heinner GuioiD· 1 shared James I McDonald· 1 shared Jeff F Hiken· 1 shared Jeremy Hoog· 1 shared John R Edwards· 1 shared

Activity by Year

2016-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetics

Carlos PadillaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Unifying population structure and relatedness analysis through a coalescent approach

Diego M. Véliz-Otani, Víctor Borda, Heinner Guio, Omar Cáceres, Cesar Sanchez, Carlos Padilla, Eimear E. Kenny, Sebastian K. Zöllner, Timothy D. O’Connor

This paper introduces a coalescent-based framework to unify population structure and relatedness analysis, showing that full GRMs can replace PCs for modeling genetic covariance.

bioRxiv · Oct 16, 2025 · PreprintGenetics

Epigenetic activation of the prostaglandin receptor EP4 promotes resistance to endocrine therapy for breast cancer

Jeff F Hiken, James I McDonald, Keith F Decker, Cesar Sanchez, Jeremy Hoog, Nathan D VanderKraats, Kyle L Jung, Margaret Akinhanmi, Matthew J Ellis, John R Edwards

The paper identifies epigenetic activation of PTGER4 as a mechanism promoting resistance to aromatase inhibitors in breast cancer and suggests it as a potential therapeutic target.

bioRxiv · Jun 2, 2016Cancer Biology